Donoghue Forlines’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.66M Buy
55,115
+31,312
+132% +$2.53M 1.21% 16
2026
Q1
$1.68M Buy
23,803
+5,187
+28% +$388K 0.47% 74
2025
Q4
$1.47M Sell
18,616
-153
-0.8% -$12.1K 0.45% 85
2025
Q3
$1.55M Buy
18,769
+102
+0.5% +$8.03K 0.48% 66
2025
Q2
$1.5M Buy
18,667
+297
+2% +$22.9K 0.43% 73
2025
Q1
$1.47M Sell
18,370
-724
-4% -$60.2K 0.47% 84
2024
Q4
$1.56M Buy
+19,094
New +$1.59M 0.52% 59
2018
Q4
Sell
-288,548
Closed -$13.5M 100
2018
Q3
$13.5M Sell
288,548
-58,471
-17% -$2.67M 1.05% 41
2018
Q2
$15.1M Sell
347,019
-26,903
-7% -$1.25M 1.25% 51
2018
Q1
$17.2M Buy
373,922
+46,697
+14% +$2.27M 1.49% 29
2017
Q4
$16.5M Buy
+327,225
New +$17.2M 1.25% 56

Other funds holding MET

Donoghue Forlines's MET Position: Q2 2026 in Review

Donoghue Forlines increased its MetLife (MET) stake by 132% in Q2 2026, buying an estimated $2.53M and bringing the position to 55,115 shares worth $4.66M. The position accounts for 1.21% of the portfolio, ranked #16.

Donoghue Forlines first reported a position in MET in Q4 2017 and has held it in 11 quarters since. The position peaked at $17.2M in Q1 2018. 1,446 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Donoghue Forlines held 55,115 shares of MetLife worth $4.66M as of Q2 2026.
  • Donoghue Forlines bought 31,312 MetLife shares in Q2 2026, an estimated $2.53M.
  • MetLife made up 1.21% of Donoghue Forlines's portfolio in Q2 2026, its #16 holding.
  • Donoghue Forlines first reported a position in MetLife in Q4 2017 and has held it in 11 quarters since.
  • Donoghue Forlines's MetLife position peaked at $17.2M in Q1 2018.
  • 1,446 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Donoghue Forlines's 13F filing for Q2 2026, filed 7 Aug 2026.